MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025%- minoxidil 7% / progesterone 0.1% / tretinoin 0.025% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025%

Directions for use

da

Sincerus Florida, adverse reactions

xas

Active, inactive

sw

NDC 72934-4149-8 MINOXIDIL USP 7% / PROGESTERONE USP 0.1% / TRETINOIN USP 0.025%. Solution 600 gm

sf

MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025% 
minoxidil 7% / progesterone 0.1% / tretinoin 0.025% solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-4149
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PROGESTERONE (UNII: 4G7DS2Q64Y) (PROGESTERONE - UNII:4G7DS2Q64Y) PROGESTERONE0.1 g  in 100 g
MINOXIDIL (UNII: 5965120SH1) (MINOXIDIL - UNII:5965120SH1) MINOXIDIL7 g  in 100 g
TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN0.025 g  in 100 g
Product Characteristics
ColoryellowScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-4149-860 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product05/07/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/07/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-4149)

Revised: 5/2019
Document Id: 883a3678-fea5-2d24-e053-2995a90a0666
Set id: 883a3678-fea4-2d24-e053-2995a90a0666
Version: 1
Effective Time: 20190506
 
Sincerus Florida, LLC